These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


114 related items for PubMed ID: 8296403

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Beneficial effects of intermittent suction and pressure treatment in intermittent claudication.
    Mehlsen J, Himmelstrup H, Himmelstrup B, Winther K, Trap-Jensen J.
    Angiology; 1993 Jan; 44(1):16-20. PubMed ID: 8424580
    [Abstract] [Full Text] [Related]

  • 3. The effect of exogenous phosphocreatine on maximal walking distance, blood rheology, platelet aggregation, and fibrinolysis in patients with intermittent claudication.
    Panchenko E, Dobrovolsky A, Rogoza A, Sorokin E, Ageeva N, Markova L, Titaeva E, Anuchin V, Karpov Y, Saks V.
    Int Angiol; 1994 Mar; 13(1):59-64. PubMed ID: 8077800
    [Abstract] [Full Text] [Related]

  • 4. [Padma-28, a herbal preparation, increases walking distance in patients with intermittent claudication].
    Drabaek H, Mehlsen J, Petersen JR, Himmelstrup H, Hansen KF.
    Ugeskr Laeger; 1994 Oct 17; 156(42):6207-9. PubMed ID: 7998359
    [Abstract] [Full Text] [Related]

  • 5. Effect of the oral hypoglycaemic sulphonylurea glibenclamide, a blocker of ATP-sensitive potassium channels, on walking distance in patients with intermittent claudication.
    Mortensen UM, Nielsen-Kudsk JE, Sondergaard HM, Jakobsen P, Jensen BS, Schmitz O, Nielsen TT.
    Diabet Med; 2006 Mar 17; 23(3):327-30. PubMed ID: 16492219
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. The effects of physical training and flunarizine on walking capacity in intermittent claudication.
    Lepäntalo M, Sundberg S, Gordin A.
    Scand J Rehabil Med; 1984 Mar 17; 16(4):159-62. PubMed ID: 6397852
    [Abstract] [Full Text] [Related]

  • 9. Double-blind placebo-controlled trial of buflomedil in intermittent claudication.
    Fonseca V, Mikhailidis DP, Barradas MA, Jeremy JY, Gracey L, Dandona P.
    Int J Clin Pharmacol Res; 1988 Mar 17; 8(5):377-81. PubMed ID: 3229875
    [Abstract] [Full Text] [Related]

  • 10. Heparan sulfate in the treatment of intermittent claudication: results of a randomized, double-blind, placebo-controlled multicenter trial.
    Messa GL, Gelso E.
    Drugs Exp Clin Res; 2002 Mar 17; 28(1):37-48. PubMed ID: 12073766
    [Abstract] [Full Text] [Related]

  • 11. A randomized trial of iloprost in patients with intermittent claudication.
    Creager MA, Pande RL, Hiatt WR.
    Vasc Med; 2008 Feb 17; 13(1):5-13. PubMed ID: 18372433
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [The effect of Ginkgo biloba extract in patients with intermittent claudication].
    Drabaek H, Petersen JR, Wïnberg N, Hansen KF, Mehlsen J.
    Ugeskr Laeger; 1996 Jul 01; 158(27):3928-31. PubMed ID: 8701508
    [Abstract] [Full Text] [Related]

  • 14. A new study demonstrates the efficacy of naftidrofuryl in the treatment of intermittent claudication. Findings of the Naftidrofuryl Clinical Ischemia Study (NCIS).
    Kieffer E, Bahnini A, Mouren X, Gamand S.
    Int Angiol; 2001 Mar 01; 20(1):58-65. PubMed ID: 11342997
    [Abstract] [Full Text] [Related]

  • 15. Management of intermittent claudication with pentoxifylline: meta-analysis of randomized controlled trials.
    Hood SC, Moher D, Barber GG.
    CMAJ; 1996 Oct 15; 155(8):1053-9. PubMed ID: 8873633
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Treatment of intermittent claudication with pentoxifylline: a 12-month, randomized trial--walking distance and microcirculation.
    De Sanctis MT, Cesarone MR, Belcaro G, Nicolaides AN, Griffin M, Incandela L, Bucci M, Geroulakos G, Ramaswami G, Vasdekis S, Agus G, Bavera P, Ippolito E.
    Angiology; 2002 Oct 15; 53 Suppl 1():S7-12. PubMed ID: 11865838
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 6.